| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |